A detailed history of Nea Management Company, LLC transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Nea Management Company, LLC holds 2,437,689 shares of INZY stock, worth $7.29 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares
2,437,689
Previous 2,437,689 -0.0%
Holding current value
$7.29 Million
Previous $10.9 Million 17.26%
% of portfolio
0.97%
Previous 1.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$1.05 - $2.82 $7,024 - $18,865
-6,690 Reduced 0.27%
2,437,689 $2.56 Million
Q3 2020

Nov 06, 2020

BUY
$17.54 - $30.2 $42.9 Million - $73.8 Million
2,444,379 New
2,444,379 $64.3 Million

Others Institutions Holding INZY

About Inozyme Pharma, Inc.


  • Ticker INZY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,145,700
  • Market Cap $120M
  • Description
  • Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...
More about INZY
Track This Portfolio

Track Nea Management Company, LLC Portfolio

Follow Nea Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nea Management Company, LLC with notifications on news.